{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T17:51:41Z","timestamp":1785433901092,"version":"3.56.0"},"reference-count":82,"publisher":"MDPI AG","issue":"10","license":[{"start":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T00:00:00Z","timestamp":1779235200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100020912","name":"King Faisal University, Saudi Arabia","doi-asserted-by":"crossref","award":["KFU262465"],"award-info":[{"award-number":["KFU262465"]}],"id":[{"id":"10.13039\/501100020912","id-type":"DOI","asserted-by":"crossref"}]},{"award":["KFU262465"],"award-info":[{"award-number":["KFU262465"]}],"id":[{"id":"https:\/\/ror.org\/00dn43547","id-type":"ROR","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCM"],"abstract":"<jats:p>Individuals with cystic fibrosis (CF) face significant treatment burdens, and as life expectancy has increased, there is growing emphasis on their psychosocial well-being. Prevalence data indicate that approximately one-quarter to one-third of individuals with CF and their caregivers experience clinically significant anxiety or depression. Specifically, pooled global estimates report an anxiety prevalence of 24.9% (95% CI: 20.8\u201328.9%) and depression prevalence of 13\u201333% in adults with CF, with caregivers experiencing even higher rates (anxiety: 35\u201338%; depression: 20\u201335%). Depression is independently associated with a nearly twofold increase in mortality risk and substantially higher healthcare costs, underscoring its prognostic significance. These mental health comorbidities are consistently associated with reduced treatment adherence, diminished quality of life, increased healthcare utilisation, and decreased survival. Accordingly, psychological well-being has emerged as a key patient outcome that directly shapes engagement with care and the effectiveness of long-term CF management. International CF guidelines now recommend routine mental health screening within multidisciplinary care frameworks. Evidence-based interventions include cognitive\u2013behavioural therapy (CBT), which is endorsed as a primary treatment, although access remains limited, and stepped-care pharmacotherapy, primarily selective serotonin reuptake inhibitors (SSRIs), for moderate to severe symptoms. Telemedicine and other digital health approaches have expanded access to psychological support, with remote CBT and online programmes demonstrating feasibility and symptom improvement during the COVID-19 pandemic and beyond. The advent of CFTR modulator therapies has significantly altered clinical outcomes, enabling many patients to achieve improved lung function and daily functioning. Nevertheless, mental health challenges persist, as individuals navigate new identity shifts and anxieties despite enhanced physical health. The implementation of mental healthcare remains inconsistent; while screening rates have increased, timely follow-up and integrated psychosocial support are frequently insufficient across care centres. This narrative review highlights the ongoing need to integrate mental health management into CF care to optimise adherence, patient outcomes, and long-term survival in the current therapeutic landscape.<\/jats:p>","DOI":"10.3390\/jcm15103953","type":"journal-article","created":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T14:12:54Z","timestamp":1779286374000},"page":"3953","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Mental Health in Cystic Fibrosis in the Modulator Era: Epidemiology, Prognostic Significance, and Therapeutic Implications"],"prefix":"10.3390","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3994-0185","authenticated-orcid":false,"given":"Maryam M.","family":"Almulhem","sequence":"first","affiliation":[{"name":"Department of Respiratory Therapy, College of Applied Medical Sciences, King Faisal University, Al-Ahsa 31982, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4238-9419","authenticated-orcid":false,"given":"Rayan A.","family":"Siraj","sequence":"additional","affiliation":[{"name":"Department of Respiratory Therapy, College of Applied Medical Sciences, King Faisal University, Al-Ahsa 31982, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,5,20]]},"reference":[{"key":"ref_1","unstructured":"Cystic Fibrosis Foundation (2021). Patient Registry 2020 Annual Data Report, Cystic Fibrosis Foundation."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S2213-2600(19)30337-6","article-title":"The future of cystic fibrosis care: A global perspective","volume":"8","author":"Bell","year":"2020","journal-title":"Lancet Respir. Med."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1056\/NEJMra1300109","article-title":"Origins of cystic fibrosis lung disease","volume":"372","author":"Stoltz","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1002\/ppul.21325","article-title":"Longitudinal assessment of health-related quality of life in an observational cohort of patients with cystic fibrosis","volume":"46","author":"Sawicki","year":"2011","journal-title":"Pediatr. Pulmonol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.jcf.2012.12.009","article-title":"Treatment complexity in cystic fibrosis: Trends over time and associations with site-specific outcomes","volume":"12","author":"Sawicki","year":"2013","journal-title":"J. Cyst. Fibros."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1136\/thoraxjnl-2014-205983","article-title":"Prevalence of depression and anxiety in patients with cystic fibrosis and parent caregivers: Results of The International Depression Epidemiological Study across nine countries","volume":"69","author":"Quittner","year":"2014","journal-title":"Thorax"},{"key":"ref_7","first-page":"6708865","article-title":"Global burden of anxiety and depression among cystic fibrosis patient: Systematic review and meta-analysis","volume":"2021","author":"Guta","year":"2021","journal-title":"Int. J. Chronic Dis."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"e002606","DOI":"10.1136\/bmjresp-2024-002606","article-title":"Psychosocial and mental health in cystic fibrosis in the modern era of care: Time to evolve","volume":"12","author":"Harrigan","year":"2025","journal-title":"BMJ Open Respir. Res."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1940","DOI":"10.1016\/S0140-6736(19)32597-8","article-title":"Efficacy and safety of the elexacaftor plus tezacaftor plus ivacaftor combination regimen in people with cystic fibrosis homozygous for the F508del mutation: A double-blind, randomised, phase 3 trial","volume":"394","author":"Heijerman","year":"2019","journal-title":"Lancet"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1056\/NEJMoa1908639","article-title":"Elexacaftor-Tezacaftor-Ivacaftor for Cystic Fibrosis with a Single Phe508del Allele","volume":"381","author":"Middleton","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"e71037","DOI":"10.1002\/ppul.71037","article-title":"Elexacaftor\/Tezacaftor\/Ivacaftor Treatment Accessibility and Mental Health: Reducing Anxiety in People With Cystic Fibrosis","volume":"60","author":"Uzunoglu","year":"2025","journal-title":"Pediatr. Pulmonol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1001\/jama.2023.8120","article-title":"Cystic fibrosis: A review","volume":"329","author":"Ong","year":"2023","journal-title":"JAMA"},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"American Psychiatric Association (2013). Diagnostic and Statistical Manual of Mental Disorders, American Psychiatric Association. [5th ed.].","DOI":"10.1176\/appi.books.9780890425596"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1007\/s00127-022-02307-w","article-title":"Depression and anxiety prevalence in people with cystic fibrosis and their caregivers: A systematic review and meta-analysis","volume":"58","author":"Lord","year":"2023","journal-title":"Soc. Psychiatry Psychiatr. Epidemiol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.jcf.2024.11.006","article-title":"Elexacaftor\/tezacaftor\/ivacaftor and mental health: A workshop report from the Cystic Fibrosis Foundation\u2019s Prioritizing Research in Mental Health working group","volume":"24","author":"Bathgate","year":"2025","journal-title":"J. Cyst. Fibros."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1007\/s10567-021-00345-5","article-title":"Anxiety in children with cystic fibrosis and their parents: A systematic review","volume":"24","author":"Kimball","year":"2021","journal-title":"Clin. Child. Fam. Psychol. Rev."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1586\/ern.10.122","article-title":"Cross-cultural variations in the prevalence and presentation of anxiety disorders","volume":"11","author":"Marques","year":"2011","journal-title":"Expert. Rev. Neurother."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"2995","DOI":"10.1002\/ppul.24949","article-title":"Integration of mental health screening and treatment into cystic fibrosis clinics: Evaluation of initial implementation in 84 programs across the United States","volume":"55","author":"Quittner","year":"2020","journal-title":"Pediatr. Pulmonol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1164\/rccm.202308-1525OC","article-title":"Elexacaftor\/Tezacaftor\/Ivacaftor Treatment and Depression-related Events","volume":"209","author":"Ramsey","year":"2024","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"17534666221144211","DOI":"10.1177\/17534666221144211","article-title":"Impact of elexacaftor\/tezacaftor\/ivacaftor on depression and anxiety in cystic fibrosis","volume":"16","author":"Zhang","year":"2022","journal-title":"Ther. Adv. Respir. Dis."},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Piehler, L., Thalemann, R., Lehmann, C., Thee, S., R\u00f6hmel, J., Syunyaeva, Z., Stahl, M., Mall, M.A., and Graeber, S.Y. (2023). Effects of elexacaftor\/tezacaftor\/ivacaftor therapy on mental health of patients with cystic fibrosis. Front. Pharmacol., 14.","DOI":"10.3389\/fphar.2023.1179208"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1378\/chest.06-2474","article-title":"The association between depression, lung function, and health-related quality of life among adults with cystic fibrosis","volume":"132","author":"Riekert","year":"2007","journal-title":"Chest"},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Fidika, A., Herle, M., and Goldbeck, L. (2014). Symptoms of depression impact the course of lung function in adolescents and adults with cystic fibrosis. BMC Pulm. Med., 14.","DOI":"10.1186\/1471-2466-14-205"},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Ancel, J., Launois, C., Perotin, J.M., Ravoninjatovo, B., Mulette, P., Hagenburg, J., Malet, J., Griffon, M., Carr\u00e9, S., and Lebargy, F. (2022). Health-Related Quality of Life in Adults with Cystic Fibrosis: Familial, Occupational, Social, and Mental Health Predictors. Healthcare, 10.","DOI":"10.3390\/healthcare10071351"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"550","DOI":"10.4187\/respcare.01328","article-title":"Relationship between anxiety, depression, and quality of life in adult patients with cystic fibrosis","volume":"57","author":"Yohannes","year":"2012","journal-title":"Respir. Care"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"149","DOI":"10.5152\/ThoracResPract.2024.23112","article-title":"Impact of anxiety, depression, and coping strategies on health-related quality of life in patients with cystic fibrosis","volume":"25","author":"Ceyhan","year":"2024","journal-title":"Thorac. Res. Pract."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1016\/j.chest.2023.10.043","article-title":"Longitudinal Effects of Elexacaftor\/Tezacaftor\/Ivacaftor: Multidimensional Assessment of Neuropsychological Side Effects and Physical and Mental Health Outcomes in Adolescents and Adults","volume":"165","author":"Graziano","year":"2024","journal-title":"Chest"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"20406223241264477","DOI":"10.1177\/20406223241264477","article-title":"The impact of elexacaftor\/tezacaftor\/ivacaftor on cystic fibrosis health-related quality of life and decision-making about daily treatment regimens: A mixed methods exploratory study","volume":"15","author":"Basile","year":"2024","journal-title":"Ther. Adv. Chronic Dis."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1002\/ppul.21238","article-title":"Depressive symptoms in children with cystic fibrosis and parents and its effects on adherence to airway clearance","volume":"45","author":"Smith","year":"2010","journal-title":"Pediatr. Pulmonol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1177\/1060028013514846","article-title":"Prevalence of depression and antidepressant therapy use in a pediatric cystic fibrosis population","volume":"48","author":"Ploessl","year":"2014","journal-title":"Ann. Pharmacother."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1037\/hea0000136","article-title":"Medication beliefs mediate between depressive symptoms and medication adherence in cystic fibrosis","volume":"34","author":"Hilliard","year":"2015","journal-title":"Health Psychol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"e20240416","DOI":"10.36416\/1806-3756\/e20240416","article-title":"Depression and anxiety in adolescents with cystic fibrosis in Brazil: Prevalence, stability over time, and relationship with treatment adherence","volume":"51","author":"Rozov","year":"2025","journal-title":"J. Bras. Pneumol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1002\/ppul.22990","article-title":"Depression, illness severity, and healthcare utilization in cystic fibrosis","volume":"49","author":"Snell","year":"2014","journal-title":"Pediatr. Pulmonol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s12931-024-03089-2","article-title":"Impact of elexacaftor\/tezacaftor\/ivacaftor (ETI) on the prescription refill rate (PRR) for inhaled medications in people with CF: An Italian multicenter analysis","volume":"26","author":"Gramegna","year":"2025","journal-title":"Respir. Res."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.jcf.2020.07.020","article-title":"Decreased survival in cystic fibrosis patients with a positive screen for depression","volume":"20","author":"Schechter","year":"2021","journal-title":"J. Cyst. Fibros."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.jcf.2018.09.003","article-title":"Mental Health screening in cystic fibrosis centres across Europe","volume":"18","author":"Abbott","year":"2019","journal-title":"J. Cyst. Fibros."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1136\/thoraxjnl-2015-207488","article-title":"International committee on mental health in cystic fibrosis: Cystic fibrosis foundation and European cystic fibrosis society consensus statements for screening and treating depression and anxiety","volume":"71","author":"Quittner","year":"2016","journal-title":"Thorax"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"106955","DOI":"10.1016\/j.rmed.2022.106955","article-title":"Mental health screening in Cystic Fibrosis as an intervention: Patient and caregiver feedback on improving these processes","volume":"202","author":"Landau","year":"2022","journal-title":"Respir. Med."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"17534666221086416","DOI":"10.1177\/17534666221086416","article-title":"Caregiver burden in cystic fibrosis: A systematic literature review","volume":"16","author":"Daly","year":"2022","journal-title":"Ther. Adv. Respir. Dis."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.1002\/ppul.26400","article-title":"National integration of mental health screening and treatment into specialized care for cystic fibrosis: What predicts success?","volume":"58","author":"Quittner","year":"2023","journal-title":"Pediatr. Pulmonol."},{"key":"ref_41","doi-asserted-by":"crossref","unstructured":"Campagna, G., Tagliati, C., Giuseppetti, G.M., and Ripani, P. (2024). Treatment of Psychological Symptoms in Patients with Cystic Fibrosis. J. Clin. Med., 13.","DOI":"10.20944\/preprints202409.0535.v1"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1093\/hsw\/hlaa009","article-title":"Introduction to cystic fibrosis for mental health care coordinators and providers: Collaborating to promote wellness","volume":"45","author":"Mueller","year":"2020","journal-title":"Health Soc. Work."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"2781","DOI":"10.1002\/ppul.26101","article-title":"Feasibility and acceptability of a CF-specific cognitive-behavioral preventive intervention for adults integrated into team-based care","volume":"57","author":"Friedman","year":"2022","journal-title":"Pediatr. Pulmonol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1007\/s11136-020-02665-5","article-title":"The effect of cognitive behavioral therapy on the quality of life of breast cancer patients: A systematic review and meta-analysis of randomized controlled trials","volume":"30","author":"Getu","year":"2021","journal-title":"Qual. Life Res."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1017\/S0033291720005292","article-title":"The evidence for cognitive behavioural therapy in any condition, population or context: A meta-review of systematic reviews and panoramic meta-analysis","volume":"51","author":"Fordham","year":"2021","journal-title":"Psychol. Med."},{"key":"ref_46","doi-asserted-by":"crossref","unstructured":"Friedman, D., Kaskas, M.M., Quittner, A.L., Smith, B.A., and Georgiopoulos, A.M. (2022). Patient engagement in the development of CF-CBT: A cystic fibrosis-specific cognitive-behavioral intervention for adults. Front. Psychol., 13.","DOI":"10.3389\/fpsyg.2022.937189"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/s12955-015-0211-y","article-title":"A web-based psychological support program for caregivers of children with cystic fibrosis: A pilot study","volume":"13","author":"Fidika","year":"2015","journal-title":"Health Qual. Life Outcomes"},{"key":"ref_48","doi-asserted-by":"crossref","unstructured":"Esposito, S., Rosafio, C., Antodaro, F., Argentiero, A., Bassi, M., Becherucci, P., Bonsanto, F., Cagliero, A., Cannata, G., and Capello, F. (2023). Use of telemedicine healthcare Systems in Children and Adolescents with chronic disease or in transition stages of life: Consensus document of the Italian Society of Telemedicine (SIT), of the Italian Society of Preventive and Social Pediatrics (SIPPS), of the Italian Society of Pediatric Primary Care (SICuPP), of the Italian Federation of Pediatric Doctors (FIMP) and of the syndicate of family pediatrician doctors (SIMPeF). J. Pers. Med., 13.","DOI":"10.3390\/jpm13020235"},{"key":"ref_49","unstructured":"World Health Organization, and International Telecommunication Union (2022). WHO-ITU Global Standard for Accessibility of Telehealth Services, World Health Organization."},{"key":"ref_50","doi-asserted-by":"crossref","unstructured":"Fainardi, V., Capoferri, G., Tornesello, M., Pisi, G., and Esposito, S. (2023). Telemedicine and its application in cystic fibrosis. J. Pers. Med., 13.","DOI":"10.3390\/jpm13071041"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"1976","DOI":"10.1002\/ppul.25413","article-title":"Psychological interventions during COVID pandemic: Telehealth for individuals with cystic fibrosis and caregivers","volume":"56","author":"Graziano","year":"2021","journal-title":"Pediatr. Pulmonol."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/S0005-7894(04)80013-3","article-title":"Acceptance and commitment therapy, relational frame theory, and the third wave of behavioral and cognitive therapies","volume":"35","author":"Hayes","year":"2004","journal-title":"Behav. Ther."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.jcf.2020.11.013","article-title":"ACT with CF: A telehealth and in-person feasibility study to address anxiety and depressive symptoms among people with cystic fibrosis","volume":"20","author":"Nurse","year":"2021","journal-title":"J. Cyst. Fibros."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.jcf.2021.07.012","article-title":"Pilot RCT of a telehealth intervention to reduce symptoms of depression and anxiety in adults with cystic fibrosis","volume":"21","author":"Bathgate","year":"2022","journal-title":"J. Cyst. Fibros."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1037\/0278-6133.20.1.20","article-title":"Cognitive-behavioral stress management intervention decreases the prevalence of depression and enhances benefit finding among women under treatment for early-stage breast cancer","volume":"20","author":"Antoni","year":"2001","journal-title":"Health Psychol."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1037\/0022-006X.68.1.31","article-title":"Cognitive\u2013behavioral stress management intervention effects on anxiety, 24-hr urinary norepinephrine output, and T-cytotoxic\/suppressor cells over time among symptomatic HIV-infected gay men","volume":"68","author":"Antoni","year":"2000","journal-title":"J. Consult. Clin. Psychol."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1007\/BF03000188","article-title":"Cognitive behavioral stress management intervention improves quality of life in Spanish monolingual hispanic men treated for localized prostate cancer: Results of a randomized controlled trial","volume":"14","author":"Penedo","year":"2007","journal-title":"Int. J. Behav. Med."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"19302","DOI":"10.1007\/s12144-021-02452-6","article-title":"Is mHealth a useful therapy for improving physical or emotional health in adolescents with cystic fibrosis? A systematic review","volume":"42","year":"2023","journal-title":"Curr. Psychol."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"4687","DOI":"10.1080\/09638288.2023.2283104","article-title":"Effects of multidisciplinary rehabilitation in a patient with Ehlers-Danlos and Beh\u00e7et\u2019s syndromes: A paradigmatic case report according to the narrative medicine","volume":"46","author":"Marotta","year":"2024","journal-title":"Disabil. Rehabil."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"1604262","DOI":"10.3389\/ijph.2021.1604262","article-title":"Storytelling as a research tool used to explore insights and as an intervention in public health: A systematic narrative review","volume":"66","author":"McCall","year":"2021","journal-title":"Int. J. Public Health"},{"key":"ref_61","first-page":"1939","article-title":"Chagas disease: Tackling the invisibility through the analysis of life histories of chronic patients","volume":"27","author":"Mello","year":"2022","journal-title":"Ci\u00eancia Sa\u00fade Coletiva"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.pedn.2023.10.014","article-title":"Young children\u2019s perspectives on treatment and care: A qualitative study using narrative and play-based interviewing","volume":"73","author":"DeCosta","year":"2023","journal-title":"J. Pediatr. Nurs."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1177\/1359105319876336","article-title":"A Metacognitive Intervention of Narrative Imagery for young people with cystic fibrosis: A feasibility study","volume":"26","author":"Russell","year":"2021","journal-title":"J. Health Psychol."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1037\/1091-7527.25.2.190","article-title":"Gender differences in young adults\u2019 perceptions of living with cystic fibrosis during the transition to adulthood: A qualitative investigation","volume":"25","author":"Berge","year":"2007","journal-title":"Fam. Syst. Health"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1080\/02739610802437509","article-title":"Generalized self-efficacy, coping, and self-esteem as predictors of psychological adjustment among children with disabilities or chronic illnesses","volume":"37","author":"Dahlbeck","year":"2008","journal-title":"Child. Health Care"},{"key":"ref_66","unstructured":"O\u2019Haver, J.J. (2007). Parental Perceptions of Risk and Protective Factors Associated with the Adaptation of Siblings of Children with Cystic Fibrosis, The University of Arizona."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.jaac.2022.10.001","article-title":"Clinical practice guideline for the assessment and treatment of children and adolescents with major and persistent depressive disorders","volume":"62","author":"Walter","year":"2023","journal-title":"J. Am. Acad. Child Adolesc. Psychiatry"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"e27402","DOI":"10.1002\/ppul.27402","article-title":"Predictors of Selective Serotonin Reuptake Inhibitor Treatment Failure in Persons With Cystic Fibrosis","volume":"60","author":"Pettit","year":"2025","journal-title":"Pediatr. Pulmonol."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1080\/17425255.2023.2220960","article-title":"Drug-drug interactions involving CFTR modulators: A review of the evidence and clinical implications","volume":"19","author":"Hong","year":"2023","journal-title":"Expert. Opin. Drug Metab. Toxicol."},{"key":"ref_70","unstructured":"U.S. Food and Drug Administration (2026, January 14). FDA Drug Safety Communication: Serious CNS Reactions Possible When Linezolid (Zyvox) Is Given to Patients Taking Certain Psychiatric Medications, Available online: https:\/\/www.fda.gov\/drugs\/postmarket-drug-safety-information-patients-and-providers\/linezolid-marketed-zyvox-information."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"2606","DOI":"10.1002\/ppul.27100","article-title":"Mental health, sleep, and respiratory health after initiating elexacaftor\/tezacaftor\/ivacaftor treatment in children with cystic fibrosis","volume":"59","author":"Pham","year":"2024","journal-title":"Pediatr. Pulmonol."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"e001420","DOI":"10.1136\/bmjresp-2022-001420","article-title":"Exploring the impact of elexacaftor-tezacaftor-ivacaftor treatment on opinions regarding airway clearance techniques and nebulisers: TEMPO a qualitative study in children with cystic fibrosis, their families and healthcare professionals","volume":"9","author":"Almulhem","year":"2022","journal-title":"BMJ Open Respir. Res."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1016\/j.healun.2019.08.001","article-title":"The International Thoracic Organ Transplant Registry of the International Society for Heart and Lung Transplantation: Thirty-sixth adult lung and heart\u2013lung transplantation Report\u20142019; Focus theme: Donor and recipient size match","volume":"38","author":"Chambers","year":"2019","journal-title":"J. Heart Lung Transplant."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1378\/chest.129.5.1367","article-title":"Psychosocial issues in the assessment and management of patients undergoing lung transplantation","volume":"129","author":"Barbour","year":"2006","journal-title":"Chest"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"2595","DOI":"10.1016\/j.transproceed.2009.06.125","article-title":"Psychosomatic evaluation of patients awaiting lung transplantation","volume":"41","author":"Erim","year":"2009","journal-title":"Transplant. Proc."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1111\/jocn.15931","article-title":"The relation between psychological distress and medication adherence in lung transplant candidates and recipients: A cross-sectional study","volume":"31","author":"Heijerman","year":"2022","journal-title":"J. Clin. Nurs."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.jcf.2019.03.002","article-title":"Lung transplant referral for individuals with cystic fibrosis: Cystic Fibrosis Foundation consensus guidelines","volume":"18","author":"Ramos","year":"2019","journal-title":"J. Cyst. Fibros."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"100171","DOI":"10.1016\/j.jhlto.2024.100171","article-title":"Impact of elexacaftor-tezacaftor-ivacaftor in lung transplantation for cystic fibrosis in the United States","volume":"7","author":"Pena","year":"2025","journal-title":"JHLT Open"},{"key":"ref_79","first-page":"172","article-title":"The Transplant Evaluation Rating Scale (TERS): A tool for the psychosocial evaluation of lung transplant candidates","volume":"64","author":"Zimmermann","year":"2018","journal-title":"Z. Psychosom. Med. Psychother."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"100182","DOI":"10.1016\/j.clinsp.2023.100182","article-title":"Health-related quality of life following lung transplantation for cystic fibrosis: A systematic review","volume":"78","author":"Raguragavan","year":"2023","journal-title":"Clinics"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1002\/ppul.25859","article-title":"A survey: Understanding the health and perspectives of people with CF not benefiting from CFTR modulators","volume":"57","author":"Camacho","year":"2022","journal-title":"Pediatr. Pulmonol."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1111\/j.1525-1497.2006.00409.x","article-title":"Using the Patient Health Questionnaire-9 to measure depression among racially and ethnically diverse primary care patients","volume":"21","author":"Huang","year":"2006","journal-title":"J. Gen. Intern. Med."}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/15\/10\/3953\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T04:19:23Z","timestamp":1779423563000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/15\/10\/3953"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,20]]},"references-count":82,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2026,5]]}},"alternative-id":["jcm15103953"],"URL":"https:\/\/doi.org\/10.3390\/jcm15103953","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,20]]}}}